Work Here?
Overview
Mendel.ai uses artificial intelligence to analyze clinical data, including electronic medical records and genetic information, to speed up matching cancer patients with suitable clinical trials. Its platform analyzes diverse data sources and searches for eligible patients and relevant evidence to support oncology research and trial recruitment. Unlike some competitors, Mendel.ai emphasizes real-world data and real-world evidence, offering subscription access to its tools and providing customized solutions and consulting services. The goal is to accelerate clinical research and improve patient outcomes by making data analysis more efficient and precise in oncology trials.
About Mendel.ai
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$65.4M
Headquarters
San Jose, California
Founded
2017
Simplify's Take
What believers are saying
- 3x acceleration in AI model training via Databricks partnership expands enterprise adoption.[1]
- Hypercube Cohort achieves 5x accuracy improvement in patient cohort identification at scale.[2]
- Chart review efficiency gains of 30%+ and 10x faster querying drive customer retention.[2]
What critics are saying
- FDA regulatory scrutiny on AI clinical summaries halts pharma trial deployments by Q3 2026.[3]
- Tempus captures 40% pharma market share with 8M+ patient records by late 2026.[3]
- AWS HealthLake and PathAI's EMR integration commoditize Mendel's standalone platform value.[3]
What makes Mendel.ai unique
- Neuro-symbolic AI combines LLMs with proprietary clinical hypergraphs for clinician-like reasoning without hallucinations.[3]
- Hypercube reduces clinical trial patient matching from hundreds of days to one day.[7]
- Multi-cloud deployment on AWS, Azure, Google Cloud, and Databricks ensures vendor flexibility.[1][7]
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$65.4M
Meets
Industry Average
Funded Over
5 Rounds
Industry standards
Benefits
Remote Work Options
Professional Development Budget
Flexible Work Hours
Growth & Insights and Company News
6 month growth
↑ 4%1 year growth
↑ 7%2 year growth
↑ 12%Karim Galil, Co-Founder and Chief Executive Officer of Mendel AIUntil recently, the term “symbolic” bore negative connotations in AI because it harkened back to the failures to achieve symbolic thinking during the so-called “AI winter” of the 1980s. Since then, generative AI has demonstrated the masterly capacities of neural networks at scale.Generative AI has relieved doctors of their administrative and cognitive burdens, for example, by handling administration and paperwork, including clinical summaries. More than 70 percent of healthcare organizations are pursuing generative AI capabilities, according to McKinsey. Today, however, we see generative AI’s deficiencies, especially in medicine. It can behave like a parrot, mindlessly telling users whatever its blind algorithms have told it to say. They also “hallucinate” or invent data, unacceptably compromising care and research.AI-generated clinical summaries don’t necessarily come under FDA oversight on standards and could cause more harm than benefits, according to JAMA. These concerns are partly why large multinational technology companies have abandoned many AI-powered healthcare efforts in recent years
To offer customers a hands-on experience, Mendel AI has launched TryMe, a trial environment accessible on its website.
Mendel AI's Hypercube platform, integrated with Snowflake's Data Cloud, is set to redefine how clinical data analysis is approached, bringing about greater efficiency, accuracy, and new insights in the medical field.
Microsoft Azure customers worldwide now gain access to Mendel's Hypercube Platform to leverage advanced AI-driven clinical data analytics, enhancing healthcare decision-making with the scalability, reliability, and agility of Azure to drive application development and shape business strategies.SAN JOSE, Calif., Sept. 3, 2024 /PRNewswire/ -- Mendel, a leader in clinical artificial intelligence, today announced the availability of the Hypercube Platform in the Microsoft Azure Marketplace, an online store providing applications and services for use on Azure. Mendel customers can now take advantage of the productive and trusted Azure cloud platform, with streamlined deployment and management.Mendel's Hypercube Platform is a comprehensive clinical data analytics solution that enables healthcare organizations to unlock insights from vast amounts of structured and unstructured data. Leveraging Mendel's proprietary AI that couples large language models with a clinical hypergraph, Hypercube transforms fragmented data into meaningful clinical insights, accelerating research and improving patient care. Leading life science companies use Hypercube for patient recruitment, patient cohort identification, chart review, and analytical queries."Our collaboration with Microsoft Azure marks a significant milestone for Mendel as we expand the accessibility of our Hypercube Platform," said Dr. Karim Galil, CEO of Mendel
Empowering life science organizations to unlock the power of generative AI with 100% explainability and limited hallucinationsSAN JOSE, Calif., Aug. 20, 2024 /PRNewswire/ -- Mendel announced today that it has joined Google Cloud Partner Advantage as a Partner level partner for the Build Engagement Model, giving customers the ability to access Hypercube on Google Cloud Marketplace.As a Google Cloud partner, Mendel offers healthcare and life science customers a suite of AI-powered tools designed to transform clinical data analytics workflows. Mendel's Hypercube leverages an AI platform that couples large language models with a clinical hypergraph to unlock the vast potential of clinical data warehouses, enabling life science organizations to make more informed, data-driven decisions and improve patient outcomes.Key features of Mendel's Hypercube platform include:Hypercube Cohort : Rapidly create and refine patient cohorts with 5x increase in accuracy and scale.: Rapidly create and refine patient cohorts with 5x increase in accuracy and scale. Hypercube Charts : Chat with medical records through a user-friendly interface, completing chart reviews with 30%+ more efficiency.: Chat with medical records through a user-friendly interface, completing chart reviews with 30%+ more efficiency. Hypercube Analyst : Query clinical data with a low-code interface, enabling 10x faster querying.: Query clinical data with a low-code interface, enabling 10x faster querying. Hypercube Redact: De-identify and tokenize patient records with >99% accuracy.De-identify and tokenize patient records with >99% accuracy
There are no jobs for Mendel.ai right now.
Find jobs on Simplify and start your career today
About Mendel.ai
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$65.4M
Headquarters
San Jose, California
Founded
2017
There are no jobs for Mendel.ai right now.
Find jobs on Simplify and start your career today